Cargando…
One-step artificial antigen presenting cell-based vaccines induce potent effector CD8 T cell responses
The production and wide use of artificial antigen presenting cells (aAPCs) in the clinic as cancer immunotherapeutics are hindered by the need of identifying immunogenic cancer antigens and production of recombinant patient-specific major histocompatibility complexes (MHC) loaded with these peptides...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908577/ https://www.ncbi.nlm.nih.gov/pubmed/31831802 http://dx.doi.org/10.1038/s41598-019-55286-5 |